Insider · CIK 0001742485

Kumar Neil

Reports to the SEC for 5 companies · PALO ALTO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001742485

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-17	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−8,721 sh	$69.01	−$602K	496,965
2026-09-17	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,279 sh	$69.57	−$89K	495,686
2026-08-19	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−8,100 sh	$83.86	−$679K	507,586
2026-08-19	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,800 sh	$84.69	−$152K	505,786
2026-08-19	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−100 sh	$85.65	−$8,565	505,686
2026-08-18	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,900 sh	$81.15	−$154K	276,407
2026-08-18	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−17.3K sh	$82.21	−$1.42M	259,128
2026-08-18	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−14.6K sh	$82.99	−$1.21M	244,526
2026-08-18	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,199 sh	$83.77	−$100K	243,327
2026-08-16	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+33.5K sh	—	—	276,871
2026-08-16	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+19.6K sh	—	—	296,470
2026-08-16	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+11.6K sh	—	—	308,024
2026-08-16	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+6,520 sh	—	—	314,544
2026-08-16	BBIOBridgeBio Pharma, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−36.2K sh	$79.86	−$2.89M	278,307
2026-08-16	BBIOBridgeBio Pharma, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−33.5K sh	—	—	67,088
2026-08-16	BBIOBridgeBio Pharma, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−19.6K sh	—	—	117,596
2026-08-16	BBIOBridgeBio Pharma, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−11.6K sh	—	—	115,538
2026-08-16	BBIOBridgeBio Pharma, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−6,520 sh	—	—	91,274
2026-06-16	BBOTBridgeBio Oncology Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+31.7K sh	—	—	31,675
2026-06-05	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−7,147 sh	$67.20	−$480K	528,539
2026-06-05	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−8,437 sh	$67.88	−$573K	520,102
2026-06-05	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−4,416 sh	$68.96	−$305K	515,686
2026-06-05	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−7,148 sh	$67.20	−$480K	4,331,299
2026-06-05	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−8,437 sh	$67.88	−$573K	4,322,862
2026-06-05	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−4,415 sh	$68.96	−$304K	4,318,447
2026-06-04	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,200 sh	$65.72	−$145K	553,486
2026-06-04	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,429 sh	$66.72	−$95.3K	552,057
2026-06-04	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−15.9K sh	$67.74	−$1.08M	536,136
2026-06-04	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−450 sh	$68.27	−$30.7K	535,686
2026-06-04	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,200 sh	$65.72	−$145K	4,356,247
2026-06-04	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,429 sh	$66.72	−$95.3K	4,354,818
2026-06-04	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−15.9K sh	$67.74	−$1.08M	4,338,897
2026-06-04	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−450 sh	$68.27	−$30.7K	4,338,447
2026-05-21	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,256 sh	$67.57	−$152K	267,174
2026-05-21	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−6,725 sh	$68.30	−$459K	260,449
2026-05-21	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−5,072 sh	$69.22	−$351K	255,377
2026-05-21	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−11.3K sh	$70.48	−$793K	244,127
2026-05-21	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−800 sh	$70.92	−$56.7K	243,327
2026-05-16	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+33.5K sh	—	—	267,995
2026-05-16	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+19.6K sh	—	—	287,594
2026-05-16	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+11.6K sh	—	—	299,147
2026-05-16	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+6,519 sh	—	—	305,666
2026-05-16	BBIOBridgeBio Pharma, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−36.2K sh	$66.13	−$2.4M	269,430
2026-05-16	BBIOBridgeBio Pharma, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−33.5K sh	—	—	100,632
2026-05-16	BBIOBridgeBio Pharma, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−19.6K sh	—	—	137,195
2026-05-16	BBIOBridgeBio Pharma, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−11.6K sh	—	—	127,092
2026-05-16	BBIOBridgeBio Pharma, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−6,519 sh	—	—	97,794
2026-05-08	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−14K sh	$66.65	−$931K	561,713
2026-05-08	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−5,077 sh	$67.35	−$342K	556,636
2026-05-08	BBIOBridgeBio Pharma, Inc.S Sale	Director, Chief Executive Officer	SSale	−950 sh	$68.35	−$64.9K	555,686

Recent filings

Accepted (ET)
Sep 214
Kumar Neil0001470831-26-000897
SEC(opens sec.gov)
Aug 204
Kumar Neil0001470831-26-000848
SEC(opens sec.gov)
Aug 184
Kumar Neil0001470831-26-000836
SEC(opens sec.gov)
Jun 184
Kumar Neil0001193125-26-276033
SEC(opens sec.gov)
Jun 84
Kumar Neil0001470831-26-000523
SEC(opens sec.gov)

Companies

Address

C/O BRIDGEBIO PHARMA, INC. 3160 PORTER DR., SUITE 250

PALO ALTO, CA, 94304